We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

197 hedge funds and large institutions have $1.92B invested in Select Medical in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,390% more call options, than puts

Call options by funds: $3.67M | Put options by funds: $246K

2% more capital invested

Capital invested by funds: $1.87B → $1.92B (+$46.6M)

0.18% more ownership

Funds ownership: 142.93%143.12% (+0.18%)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

1% less funds holding

Funds holding: 198197 (-1)

16% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 75

Holders
197
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
63
Reduced
75
Closed
24
Calls
$3.67M
Puts
$246K
Net Calls
+$3.42M
Net Calls Change
+$3.55M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$370M +$980K +94,649 +0.3%
BlackRock
2
BlackRock
New York
$297M +$17.7M +1,706,607 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$193M +$1.49M +144,048 +0.7%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$139M -$4.54M -438,183 -3%
Fisher Asset Management
5
Fisher Asset Management
Washington
$78.4M -$106K -10,223 -0.1%
Invesco
6
Invesco
Georgia
$77.2M +$12.2M +1,177,281 +18%
State Street
7
State Street
Massachusetts
$59.2M +$3.97M +383,593 +7%
Northern Trust
8
Northern Trust
Illinois
$39.4M -$1.5M -144,451 -4%
Victory Capital Management
9
Victory Capital Management
Texas
$38.5M +$5.2M +502,045 +15%
Norges Bank
10
Norges Bank
Norway
$35.8M
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$31.8M +$23.8M +2,295,489 +251%
TCM
12
TimesSquare Capital Management
New York
$31.6M +$33.1M +3,192,320 New
VOYA Investment Management
13
VOYA Investment Management
Georgia
$28.3M -$8.4M -810,940 -22%
DM
14
Deerfield Management
New York
$28.1M -$6.38M -616,192 -18%
HRCM
15
Hood River Capital Management
Florida
$26.5M -$5.72M -552,878 -17%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$25.1M +$1.93M +186,539 +8%
Charles Schwab
17
Charles Schwab
California
$21.3M +$1.91M +184,800 +9%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$19.3M +$1.27M +122,420 +7%
O
19
OrbiMed
New York
$19M -$77.6M -7,497,291 -80%
Principal Financial Group
20
Principal Financial Group
Iowa
$17.1M +$858K +82,878 +5%
MFIMFI
21
Mesirow Financial Investment Management - Fixed Income
Illinois
$16.3M +$17M +1,645,125 New
Boston Partners
22
Boston Partners
Massachusetts
$15.7M -$400K -38,588 -2%
RI
23
Redwood Investments
Massachusetts
$13.2M +$13.8M +1,333,044 New
Morgan Stanley
24
Morgan Stanley
New York
$12.3M +$7.6M +733,851 +146%
Ameriprise
25
Ameriprise
Minnesota
$11.4M +$351K +33,870 +3%

SEM Hedge Fund Activity: Q3 2018 in Review

197 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2018, worth a combined $1.92B — up 2.5% from $1.87B a quarter earlier.

Fund positioning in SEM was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 63 added to existing stakes and 75 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $33.1M. The largest seller was OrbiMed, cutting an estimated $77.6M.

  • 197 institutional investors held Select Medical (SEM) as of Q3 2018, down from 198 in Q2 2018.
  • Funds reported $1.92B of Select Medical stock for Q3 2018, up 2.5% quarter-over-quarter.
  • 24 funds opened new Select Medical positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Select Medical buyer in Q3 2018 was TimesSquare Capital Management, an estimated $33.1M added.
  • The largest Select Medical seller in Q3 2018 was OrbiMed, an estimated $77.6M sold.

Based on aggregated 13F filings for Q3 2018.